Highlights and Quick Summary
- Capital expenditures for the quarter ending June 30, 2021 was $-346 Thousand (a -37.2% decrease compared to previous quarter)
- Year-over-year quarterly Capital expenditures increased by 17.46%
- Annual Capital expenditures for 2021 was $-744 Thousand (a -3.34% decrease from previous year)
- Annual Capital expenditures for 2020 was $-770 Thousand (a -60.96% decrease from previous year)
- Annual Capital expenditures for 2019 was $-1.97 Million (a 226.81% increase from previous year)
- Twelve month Capital expenditures ending June 30, 2021 was $-1.63 Million (a 20.32% increase compared to previous quarter)
Trailing Capital expenditures for the last four month:
| 30 Jun '21 | 30 Jun '20 | 30 Sep '18 | — |
|---|---|---|---|
| $-1.63 Million | $-1.35 Million | $-1.3 Million | — |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capital expenditures of Biofrontera AG Sponsored ADR
Most recent Capital expendituresof BFAGY including historical data for past 10 years.Interactive Chart of Capital expenditures of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Capital expenditures for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | $-0.35 | $-0.74 |
| 2020 | – | – | – | $-0.55 | $-0.77 |
| 2019 | – | – | – | – | $-1.97 |
| 2018 | – | – | – | $-0.44 | $-0.6 |
| 2017 | – | – | $-0.29 | $-0.07 | $-0.43 |
| 2016 | $-0.5 | – | – | – | $-0.51 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic